Integrating AI with care: FDA reveals focus areas for forthcoming guidance on AI products
Posted:
The FDA is focusing on integrating #AI with care, outlining key areas for forthcoming guidance on AI products. As AI technology expands, it's crucial to ensure safe implementation.
In Bold Insight latest blog, Stephanie Wiltman breaks down the FDA's focus areas and how they'll shape the future of AI in healthcare.
Every newborn baby in England will have their DNA mapped to assess their risk of hundreds of diseases, under NHS plans for the next 10 years.
Read more here.
Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual physical therapy platform.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us